IDH2 and central nervous system cancer: According to 2016 WHO classification of gliomas [25], grade II/III gliomas can be grouped into three subtypes: IDH-wildtype, IDH-mutant/1p19q-codeleted and IDH-mutant/non-1p19q-codeleted gliomas.